BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24948145)

  • 21. Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells.
    Roth W; Wild-Bode C; Platten M; Grimmel C; Melkonyan HS; Dichgans J; Weller M
    Oncogene; 2000 Aug; 19(37):4210-20. PubMed ID: 10980594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The DNA methylome of glioblastoma multiforme.
    Martinez R; Esteller M
    Neurobiol Dis; 2010 Jul; 39(1):40-6. PubMed ID: 20064612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-153 as a Tumor Suppressor in Glioblastoma Multiforme is Downregulated by DNA Methylation.
    Ghasemi A; Fallah S; Ansari M
    Clin Lab; 2016; 62(4):573-80. PubMed ID: 27215075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The SFRP family of WNT inhibitors function as novel tumor suppressor genes epigenetically silenced in medulloblastoma.
    Kongkham PN; Northcott PA; Croul SE; Smith CA; Taylor MD; Rutka JT
    Oncogene; 2010 May; 29(20):3017-24. PubMed ID: 20208569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hypermethylation and regulation of expression of secreted frizzled-related protein genes in colorectal tumor].
    Qi J; Zhu YQ; Luo J; Tao WH; Zhang JM
    Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):842-5. PubMed ID: 18396643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in beta-catenin-deficient human mesothelioma cells.
    He B; Lee AY; Dadfarmay S; You L; Xu Z; Reguart N; Mazieres J; Mikami I; McCormick F; Jablons DM
    Cancer Res; 2005 Feb; 65(3):743-8. PubMed ID: 15705870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma.
    Donson AM; Addo-Yobo SO; Handler MH; Gore L; Foreman NK
    Pediatr Blood Cancer; 2007 Apr; 48(4):403-7. PubMed ID: 16609952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of lomeguatrib-temozolomide combination on MGMT promoter methylation and expression in primary glioblastoma tumor cells.
    Taspinar M; Ilgaz S; Ozdemir M; Ozkan T; Oztuna D; Canpinar H; Rey JA; Sunguroğlu A; Castresana JS; Ugur HC
    Tumour Biol; 2013 Jun; 34(3):1935-47. PubMed ID: 23519841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic Modification of MicroRNA-219-1 and Its Association with Glioblastoma Multiforme.
    Ghasemi A; Mohammadi A; Fallah S
    Biochemistry (Mosc); 2021 Apr; 86(4):420-432. PubMed ID: 33941064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic Modification of MicroRNA-205 and its Association with Glioblastoma Multiform.
    Ghasemi A; Fallah S
    Clin Lab; 2017 Jul; 63(7):1079-1088. PubMed ID: 28792704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic modulation of the drug resistance genes MGMT, ABCB1 and ABCG2 in glioblastoma multiforme.
    Oberstadt MC; Bien-Möller S; Weitmann K; Herzog S; Hentschel K; Rimmbach C; Vogelgesang S; Balz E; Fink M; Michael H; Zeden JP; Bruckmüller H; Werk AN; Cascorbi I; Hoffmann W; Rosskopf D; Schroeder HW; Kroemer HK
    BMC Cancer; 2013 Dec; 13():617. PubMed ID: 24380367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition.
    Quan H; Zhou F; Nie D; Chen Q; Cai X; Shan X; Zhou Z; Chen K; Huang A; Li S; Tang N
    Oncogene; 2014 May; 33(22):2826-35. PubMed ID: 23770846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversing HOXA9 oncogene activation by PI3K inhibition: epigenetic mechanism and prognostic significance in human glioblastoma.
    Costa BM; Smith JS; Chen Y; Chen J; Phillips HS; Aldape KD; Zardo G; Nigro J; James CD; Fridlyand J; Reis RM; Costello JF
    Cancer Res; 2010 Jan; 70(2):453-62. PubMed ID: 20068170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer.
    Cheng YY; Yu J; Wong YP; Man EP; To KF; Jin VX; Li J; Tao Q; Sung JJ; Chan FK; Leung WK
    Br J Cancer; 2007 Oct; 97(7):895-901. PubMed ID: 17848950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuclear phosphorylated Y142 β-catenin accumulates in astrocytomas and glioblastomas and regulates cell invasion.
    Náger M; Santacana M; Bhardwaj D; Valls J; Ferrer I; Nogués P; Cantí C; Herreros J
    Cell Cycle; 2015; 14(22):3644-55. PubMed ID: 26654598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secreted frizzled-related protein-5 is epigenetically downregulated and functions as a tumor suppressor in kidney cancer.
    Kawakami K; Yamamura S; Hirata H; Ueno K; Saini S; Majid S; Tanaka Y; Kawamoto K; Enokida H; Nakagawa M; Dahiya R
    Int J Cancer; 2011 Feb; 128(3):541-50. PubMed ID: 20340127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma.
    Lee AY; He B; You L; Dadfarmay S; Xu Z; Mazieres J; Mikami I; McCormick F; Jablons DM
    Oncogene; 2004 Aug; 23(39):6672-6. PubMed ID: 15221014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Promoter methylation status of SFRP genes and induced apoptosis by demethylation in Jurkat cells].
    Xu C; Shen J; Liao B; Fu H; Zhou H; Qi Y; Huangfu Z; Chen Y; Chen J
    Zhonghua Xue Ye Xue Za Zhi; 2016 Jan; 37(1):51-5. PubMed ID: 26876254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection.
    Urakami S; Shiina H; Enokida H; Kawakami T; Kawamoto K; Hirata H; Tanaka Y; Kikuno N; Nakagawa M; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2109-16. PubMed ID: 16609023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
    Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
    Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.